Feed BNGO
BN

Bionano Genomics, Inc.

BNGO · NASDAQ

$1.73 -1.14% (-$0.02)
1M +41.80%
Market Cap $19.9M
P/E Ratio -
Div. Yield -
ROE 78.78%
Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/S 0.66x
P/B 0.63x
P/E N/A
Growth
19 /100
Declining
Rev. growth 0.84%
Book val. growth 43.73%
EPS growth N/A
Profitability
19 /100
Weak
Gross margin 47.50%
Net margin 106.58%
Op. margin 106.67%
Quality
8 /100
Poor
ROIC 83.94%
ROE 78.78%
ROA 67.58%
Debt
69 /100
Low
Debt/Equity 0.21x
Current ratio 2.48x
Int. coverage -149.69x
Stability
20 /100
Unstable
Beta 1.65x
Rev. volatility 23.95%
EPS volatility 80.71%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BNGO
Online

O podjetju

Bionano Genomics (BNGO) is a biotechnology company focused on developing and commercializing its advanced genomic platform. This platform enables the study of the structure and variations of the human genome with high accuracy and detail. Bionano Genomics aims to provide tools for genetic research, genetic disease diagnostics, and personalized medicine. Bionano Genomics stock is suitable for investors interested in the biotechnology sector and innovative technologies in the field of genetics. Add Bionano Genomics stock to your watchlist on Bulios and stay informed about the latest advancements in genomics and biotechnology.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Albert A. Luderer

Employees

96

Headquarters

San Diego

Prihajajoči dogodki

12 NOV.

Earnings

Upcoming earnings report

52d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.